SEARCH

SEARCH BY CITATION

References

  • 1
    Reinhold-Keller E, Beuge N, Latza U et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Arthritis Rheum 2000; 43:102132.
  • 2
    Matsubara O, Yoshimura N, Doi Y, Tamura A, Mark EJ. Nasal biopsy in the diagnosis of early Wegener's (pathergic) granulomatosis. Virchows Arch 1996; 428:139.
  • 3
    Godman GC & Churg J. Wegener's granulomatosis pathology and review of the literature. Arch Pathol 1954; 58:53351.
  • 4
    Goldschmeding R, Van Der Schoot CE, Ten Bokkel Huinink D et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorphosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989; 84:157787.
  • 5
    Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41:37583.
  • 6
    Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Pathol 1992; 141:33542.
  • 7
    Cockwell P, Brooks CJ, Adu D, Savage COS. Interleukin-8: a pathogenic role in antineutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis. Kidney Int 1999; 55:85263.DOI: 10.1046/j.1523-1755.1999.055003852.x
  • 8
    Cunningham MA, Huang XR, Dowling JP, Tipping PG, Holdsworth SR. Prominence of cell-mediated immunity effectors in ‘pauci-immune’ glomerulonephritis. J Am Soc Nephrol 1999; 10:499506.
  • 9
    Brouwer E, Stegeman CA, Huitema G, Limburg PC, Kallenberg CGM. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994; 98:44853.
  • 10
    Griffith ME, Coulthart A, Pusey CD. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol 1996; 103:2538.
  • 11
    King WJ, Brooks CJ, Holder R, Hughes P, Adu D, Savage C. T lymphocyte responses to ANCA antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol 1998; 112:53946.DOI: 10.1046/j.1365-2249.1998.00615.x
  • 12
    Csernok E, Trabandt A, Muller A et al. Cytokine profiles in Wegener's granulomatosis: Predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999; 42:74250.
  • 13
    Ludviksson BR, Sneller MC, Chua KS et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998; 160:36029.
  • 14
    Mosmann TR & Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46:1114.
  • 15
    Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:2779.
  • 16
    Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: the proposal of an International Consensus Conference. Arth Rheum 1994; 37:18792.
  • 17
    Cockwell P & Savage COS. Glycosaminoglycans contribute to multiple finctions of vascular endothelial cells. Clin Exp Immunol 1996; 104:13.
  • 18
    Cockwell P, Adams DH, Savage COS. Glycosaminoglycans contribute to multiple functions of vascular endothelial cells. Clin Exp Immunol 1996; 104:13.
  • 19
    Stegeman C, Cohen Tervaert J, De Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 335:1620.
  • 20
    Mayet W-J, Marker-Hermann E, Schlaak J, Zum Buschenfelde K-H. Irregular cytokine pattern of CD4+ T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis. Scand J Immunol 1999; 49:58594.DOI: 10.1046/j.1365-3083.1999.00544.x